Federated Hermes Inc. Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Federated Hermes Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 322,713 shares of the medical equipment provider’s stock after purchasing an additional 9,392 shares during the period. Federated Hermes Inc. owned 0.09% of Intuitive Surgical worth $159,830,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ISRG. GAMMA Investing LLC increased its position in Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the period. Capital Research Global Investors grew its position in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Northern Trust Corp grew its position in shares of Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after buying an additional 494,496 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $167,943,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Intuitive Surgical by 12.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider’s stock worth $1,475,566,000 after buying an additional 319,694 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $493.95 on Tuesday. The firm has a fifty day moving average price of $528.51 and a 200 day moving average price of $534.63. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a market cap of $177.07 billion, a P/E ratio of 68.89, a P/E/G ratio of 5.20 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.78 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ISRG. Truist Financial lifted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Royal Bank Of Canada lifted their price objective on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 23rd. UBS Group lifted their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Citigroup reaffirmed a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, BTIG Research boosted their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $592.05.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president owned 907 shares of the company’s stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,610 shares of company stock worth $3,858,340. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.